SPINK5 (Q9NQ38) variants and mutations
SPINK5 (also known as Q9NQ38) is a human protein-coding gene encoding a serine protease inhibitor Kazal-type 5 protein. Its processed inhibitory domains restrain epidermal serine proteases and protect the skin barrier from excessive proteolysis and inflammation. Biallelic loss-of-function variants cause Netherton syndrome with ichthyosis, hair-shaft defects, severe atopy, and infection risk. This analysis covers 1,687 SPINK5 variants and mutations. Of these, 66% have computational variant effect predictions. Disease context includes Netherton syndrome, ichthyosis linearis circumflexa, and erythematosquamous dermatosis. Example SPINK5 variants include M1?, M1K, and K2N.
Variant analysis overview
- Gene: SPINK5
- Protein: Q9NQ38
- UniProt accession: Q9NQ38
- Organism: Homo sapiens
- Variants analyzed: 1687
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 1,548 unspecified-consequence records; 68 missense variants; 46 synonymous variants; 15 frameshift variants; 3 stop-gained variants; 3 splice-region variants; 1 in-frame deletions; 1 in-frame insertions; 3 substitution
- Prediction scores: 1,111 variants have prediction scores (66% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Netherton syndrome, ichthyosis linearis circumflexa, erythematosquamous dermatosis, seborrheic dermatitis, atopic IgE-mediated allergic disorder, IgE responsiveness, atopic, exfoliative dermatitis, Increased circulating IgE concentration, neurodegenerative disease, hereditary disease, ovarian dysfunction, erythrokeratodermia variabilis.
Protein structure and variant hotspots
- Protein features: 15 domains.
- Structural context: 1,424 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SPINK5 variants
Examples include M1?, M1K, K2N, K2Q, K2R, I3T, A4T, A4V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV56250
- M1K (p.Met1Lys), rs2531633162, ClinGen CA361887268, ClinVar RCV003763225, Uncertain significance, Ichthyosis linearis circumflexa
- K2N (p.Lys2Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K2Q (p.Lys2Gln), rs2127180920, ClinGen CA361887278, ClinVar RCV002031062, Ensembl rs2127180920, Uncertain significance, Netherton syndrome
- K2R (p.Lys2Arg), ExAC rs780256328, TOPMed rs780256328, gnomAD rs780256328
- I3T (p.Ile3Thr), gnomAD rs1317545554, REVEL 0.02, MetaLR 0.05
- A4T (p.Ala4Thr), Ensembl rs1752512067, REVEL 0.04, MetaLR 0.10
- A4V (p.Ala4Val), ExAC rs747877527, gnomAD rs747877527, REVEL 0.07, MetaLR 0.12
- A4D (p.Ala4Asp), gnomAD 5-148064055-C-A, REVEL 0.20, MetaLR 0.17
- A4A (p.Ala4Ala), gnomAD 5-148064056-C-A, CADD 1.48
- T5I (p.Thr5Ile), TOPMed rs1752512387, REVEL 0.10, MetaLR 0.24
- T5P (p.Thr5Pro), ExAC rs769595604, gnomAD rs769595604, REVEL 0.13, MetaLR 0.20, Uncertain significance, not provided
- T5A (p.Thr5Ala), gnomAD 5-148064057-A-G, REVEL 0.02, MetaLR 0.11
- T5T (p.Thr5Thr), gnomAD 5-148064059-A-C, CADD 2.34
- V6M (p.Val6Met), gnomAD 5-148064060-G-A, REVEL 0.18, MetaLR 0.28
- V6L (p.Val6Leu), gnomAD 5-148064060-G-C, REVEL 0.12, MetaLR 0.31
- V6A (p.Val6Ala), gnomAD 5-148064061-T-C, REVEL 0.16, MetaLR 0.27
- V6V (p.Val6Val), gnomAD 5-148064062-G-A, CADD 3.26
- S7L (p.Ser7Leu), gnomAD rs1264539510, REVEL 0.18, MetaLR 0.06
- S7P (p.Ser7Pro), rs1752512482, ClinGen CA361887334, cosmic curated COSV56255, ClinVar RCV003770606, Uncertain significance, Ichthyosis linearis circumflexa
- S7S (p.Ser7Ser), rs1468320558, gnomAD 5-148064065-A-T, CADD 1.39
- V8M (p.Val8Met), ExAC rs777647928, gnomAD rs777647928, REVEL 0.02, MetaLR 0.02
- V8V (p.Val8Val), rs1231950922, gnomAD 5-148064068-G-A, CADD 4.17
- L9F (p.Leu9Phe), gnomAD rs1199937281, REVEL 0.18, MetaLR 0.32, Uncertain significance, Inborn genetic diseases
- L9R (p.Leu9Arg), cosmic curated COSV56251
- L9L (p.Leu9Leu), gnomAD 5-148064071-T-A, CADD 7.13
- L10L (p.Leu10Leu), rs960102038, gnomAD 5-148064074-G-C, CADD 6.64
- P11P (p.Pro11Pro), gnomAD 5-148064077-C-G, CADD 7.11
- L12S (p.Leu12Ser), NCI-TCGA Cosmic COSV5626, cosmic curated COSV56261, Variant assessed as somatic; moderate impact.
- L12F (p.Leu12Phe), gnomAD 5-148064076-CCTTG, CADD 28.50
- A13S (p.Ala13Ser), rs2127180984, ClinGen CA361887389, cosmic curated COSV10954, ClinVar RCV003772993, REVEL 0.19, MetaLR 0.33, Uncertain significance, Ichthyosis linearis circumflexa
- A13V (p.Ala13Val), gnomAD 5-148064082-C-T, REVEL 0.10, MetaLR 0.29
- A13D (p.Ala13Asp), gnomAD 5-148064082-C-A, REVEL 0.24, MetaLR 0.27
- L14F (p.Leu14Phe), NCI-TCGA Cosmic COSV5626, NCI-TCGA Cosmic COSV9980, Variant assessed as somatic; high impact.
- L14I (p.Leu14Ile), NCI-TCGA Cosmic COSV5626, NCI-TCGA Cosmic COSV9980, cosmic curated COSV99805, Variant assessed as somatic; moderate impact.
- L14V (p.Leu14Val), cosmic curated COSV56261, ExAC rs749263067, gnomAD rs749263067, REVEL 0.03, MetaLR 0.09
- C15* (p.Cys15Ter), rs770450773, ClinGen CA3495075, ClinVar RCV003596124, ExAC rs770450773, CADD 35.00, Pathogenic
- C15Y (p.Cys15Tyr), Ensembl rs992803751, REVEL 0.20, MetaLR 0.07
- C15F (p.Cys15Phe), gnomAD 5-148064088-G-T, REVEL 0.18, MetaLR 0.09
- L16F (p.Leu16Phe), rs370369039, ClinGen CA3495076, ClinVar RCV002543489, ClinVar RCV005095336, REVEL 0.03, MetaLR 0.11, Uncertain significance, Ichthyosis linearis circumflexa; Inborn genetic diseases
- L16V (p.Leu16Val), 1000Genomes rs370369039, ExAC rs370369039, TOPMed rs370369039, gnomAD rs370369039, REVEL 0.04, MetaLR 0.16, Uncertain significance
- L16P (p.Leu16Pro), rs1752513374, gnomAD 5-148064088-G-GC, CADD 29.00
- L16L (p.Leu16Leu), rs374054110, gnomAD 5-148064092-C-T, CADD 8.43
- I17V (p.Ile17Val), gnomAD rs1421879211, REVEL 0.02, MetaLR 0.07
- I17T (p.Ile17Thr), gnomAD 5-148064094-T-C, REVEL 0.10, MetaLR 0.07
- I17M (p.Ile17Met), gnomAD 5-148064095-A-G, REVEL 0.10, MetaLR 0.15
- Q18* (p.Gln18Ter), gnomAD 5-148064096-C-T, CADD 36.00
- Q18E (p.Gln18Glu), gnomAD 5-148064096-C-G, REVEL 0.09, MetaLR 0.22
- Q18Q (p.Gln18Gln), rs1164321753, gnomAD 5-148064098-A-G, CADD 22.20
- Q18H (p.Gln18His), gnomAD 5-148064098-A-T, REVEL 0.11, MetaLR 0.30
- D19A (p.Asp19Ala), rs1204188199, ClinGen CA361887442, ClinVar RCV001924958, TOPMed rs1204188199, REVEL 0.19, MetaLR 0.15, Uncertain significance, Netherton syndrome
- A20V (p.Ala20Val), rs777592836, ClinGen CA3495090, NCI-TCGA Cosmic COSV5625, cosmic curated COSV56259, REVEL 0.04, MetaLR 0.10, Uncertain significance, Netherton syndrome
- A21G (p.Ala21Gly), TOPMed rs1250498241
- S22G (p.Ser22Gly), rs2127182478, ClinGen CA361887459, ClinVar RCV003772863, Ensembl rs2127182478, Uncertain significance, Ichthyosis linearis circumflexa
- K23* (p.Lys23Ter), rs1482249008, ClinGen CA361887468, ClinVar RCV003763924, gnomAD rs1482249008, CADD 36.00, Pathogenic
- K23T (p.Lys23Thr), 1000Genomes rs566891063, ExAC rs566891063, gnomAD rs566891063, REVEL 0.05, MetaLR 0.06
- N24Y (p.Asn24Tyr), 1000Genomes rs527779780, ExAC rs527779780, gnomAD rs527779780, REVEL 0.04, MetaLR 0.06
- N24H (p.Asn24His), gnomAD 5-148065361-A-C, REVEL 0.04, MetaLR 0.07
- N24D (p.Asn24Asp), gnomAD 5-148065361-A-G, REVEL 0.02, MetaLR 0.03
- N24T (p.Asn24Thr), gnomAD 5-148065362-A-C, REVEL 0.03, MetaLR 0.06
- E25E (p.Glu25Glu), gnomAD 5-148065366-A-G, CADD 11.40
- D26E (p.Asp26Glu), TOPMed rs1478894570, gnomAD rs1478894570, REVEL 0.07, MetaLR 0.06
- D26Y (p.Asp26Tyr), TOPMed rs1752552183
- D26V (p.Asp26Val), gnomAD 5-148065368-A-T, REVEL 0.13, MetaLR 0.07
- Q27* (p.Gln27Ter), cosmic curated COSV10639, CADD 49.00
- Q27R (p.Gln27Arg), rs778915520, ClinGen CA3495094, cosmic curated COSV56263, ClinVar RCV003763944, REVEL 0.10, MetaLR 0.13, Conflicting interpretations, Ichthyosis linearis circumflexa; Netherton syndrome
- Q27E (p.Gln27Glu), gnomAD 5-148065370-C-G, REVEL 0.09, MetaLR 0.12
- E28K (p.Glu28Lys), cosmic curated COSV56249
- M29I (p.Met29Ile), TOPMed rs1752703716, REVEL 0.01, MetaLR 0.00
- M29V (p.Met29Val), rs946715933, ClinGen CA129717598, ClinVar RCV003595721, TOPMed rs946715933, REVEL 0.01, MetaLR 0.01, Uncertain significance, Ichthyosis linearis circumflexa
- C30R (p.Cys30Arg), Ensembl rs1752703805
- C30Y (p.Cys30Tyr), ExAC rs753511595, gnomAD rs753511595, REVEL 0.28, MetaLR 0.11
- C30F (p.Cys30Phe), gnomAD 5-148070330-G-T, REVEL 0.28, MetaLR 0.11
- H31P (p.His31Pro), TOPMed rs1752703984, gnomAD rs1752703984
- H31R (p.His31Arg), TOPMed rs1752703984, gnomAD rs1752703984, REVEL 0.01, MetaLR 0.01
- H31Y (p.His31Tyr), NCI-TCGA Cosmic COSV5624, cosmic curated COSV56249, REVEL 0.01, MetaLR 0.01, Variant assessed as somatic; moderate impact.
- H31H (p.His31His), gnomAD 5-148070334-T-C, CADD 3.07
- E32K (p.Glu32Lys), NCI-TCGA Cosmic COSV5624, cosmic curated COSV56248, Variant assessed as somatic; moderate impact.
- F33Y (p.Phe33Tyr), ExAC rs757090351, TOPMed rs757090351, gnomAD rs757090351, REVEL 0.10, MetaLR 0.01
- F33V (p.Phe33Val), gnomAD 5-148070338-T-G, REVEL 0.15, MetaLR 0.02
- F33S (p.Phe33Ser), gnomAD 5-148070339-T-C, REVEL 0.17, MetaLR 0.02
- Q34* (p.Gln34Ter), NCI-TCGA Cosmic COSV9980, cosmic curated COSV99806, Variant assessed as somatic; high impact.
- Q34K (p.Gln34Lys), ESP rs376417849, ExAC rs376417849, TOPMed rs376417849, gnomAD rs376417849, REVEL 0.05, MetaLR 0.02, Uncertain significance, Inborn genetic diseases; not specified
- A35T (p.Ala35Thr), Ensembl rs1581049399
- A35A (p.Ala35Ala), rs200250655, gnomAD 5-148070346-A-T, CADD 2.83
- F36L (p.Phe36Leu), gnomAD 5-148070347-T-C, REVEL 0.01, MetaLR 0.00
- M37I (p.Met37Ile), cosmic curated COSV10639, REVEL 0.08, MetaLR 0.02
- M37T (p.Met37Thr), gnomAD rs1752704518, REVEL 0.07, MetaLR 0.03
- N39D (p.Asn39Asp), rs2531645995, ClinGen CA361888253, ClinVar RCV003764025, REVEL 0.09, MetaLR 0.03, Uncertain significance, Ichthyosis linearis circumflexa
- N39S (p.Asn39Ser), ExAC rs757954624, gnomAD rs757954624, REVEL 0.07, MetaLR 0.02
- N39K (p.Asn39Lys), gnomAD 5-148070358-T-A, REVEL 0.05, MetaLR 0.02
- G40A (p.Gly40Ala), rs73269156, ClinGen CA3495114, ClinVar RCV000265588, ClinVar RCV001706573, REVEL 0.27, MetaLR 0.02, Benign/Likely benign, Ichthyosis linearis circumflexa; not provided; Netherton syndrome
- K41R (p.Lys41Arg), ExAC rs746648914, TOPMed rs746648914, gnomAD rs746648914, Uncertain significance
- K41T (p.Lys41Thr), rs746648914, ClinGen CA3495115, ClinVar RCV003770936, ExAC rs746648914, REVEL 0.14, MetaLR 0.02, Uncertain significance, Ichthyosis linearis circumflexa
- K41Q (p.Lys41Gln), gnomAD 5-148070362-A-C, REVEL 0.09, MetaLR 0.05
- K41K (p.Lys41Lys), gnomAD 5-148070364-A-G, CADD 3.86
- L42L (p.Leu42Leu), rs1307672024, gnomAD 5-148070367-G-A, CADD 2.55
- F43L (p.Phe43Leu), Ensembl rs2127189521
- F43F (p.Phe43Phe), rs1752705151, gnomAD 5-148070370-C-T, CADD 5.39
- C44Y (p.Cys44Tyr), Ensembl rs2127189536
- P45H (p.Pro45His), TOPMed rs951311428, gnomAD rs951311428, REVEL 0.09, MetaLR 0.04, Uncertain significance, Inborn genetic diseases
- P45L (p.Pro45Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P45S (p.Pro45Ser), rs1025545434, ClinGen CA361888340, ClinVar RCV003368021, ClinVar RCV003761578, REVEL 0.04, MetaLR 0.01, Conflicting interpretations, Inborn genetic diseases; Ichthyosis linearis circumflexa
- P45T (p.Pro45Thr), Ensembl rs1025545434
- Q46* (p.Gln46Ter), rs886039547, ClinGen CA10588394, ClinVar RCV000255706, Ensembl rs886039547, Pathogenic
- Q46H (p.Gln46His), cosmic curated COSV56253
- Q46X, rs886039547, Pathogenic
- D47E (p.Asp47Glu), Ensembl rs1752705642
- D47N (p.Asp47Asn), cosmic curated COSV10505
- D47Y (p.Asp47Tyr), rs199620733, ClinGen CA3495116, cosmic curated COSV56249, ClinVar RCV000819283, REVEL 0.13, MetaLR 0.04, Uncertain significance, Netherton syndrome
- D47G (p.Asp47Gly), gnomAD 5-148070381-A-G, REVEL 0.04, MetaLR 0.02
- K48E (p.Lys48Glu), ExAC rs776356775, TOPMed rs776356775, gnomAD rs776356775, REVEL 0.02, MetaLR 0.02
- K48N (p.Lys48Asn), gnomAD rs1490014656, REVEL 0.01, MetaLR 0.01
- K49I (p.Lys49Ile), TOPMed rs1490557744, gnomAD rs1490557744, REVEL 0.07, MetaLR 0.02
- K49N (p.Lys49Asn), 1000Genomes rs1357830769, TOPMed rs1357830769, REVEL 0.03, MetaLR 0.01
- K49T (p.Lys49Thr), rs1490557744, NCI-TCGA Cosmic COSV5624, cosmic curated COSV56249, TOPMed rs1490557744, REVEL 0.04, MetaLR 0.01, Variant assessed as somatic; moderate impact.
- F50F (p.Phe50Phe), rs986646323, gnomAD 5-148070391-T-C, CADD 5.65
- F51L (p.Phe51Leu), TOPMed rs1296743627, gnomAD rs1296743627, REVEL 0.02, MetaLR 0.02
- F51V (p.Phe51Val), NCI-TCGA Cosmic COSV9980, cosmic curated COSV99807, Variant assessed as somatic; moderate impact.
- F51C (p.Phe51Cys), gnomAD 5-148070393-T-G, REVEL 0.09, MetaLR 0.04
- F51F (p.Phe51Phe), rs1752706399, gnomAD 5-148070394-T-C, CADD 3.48
- Q52* (p.Gln52Ter), NCI-TCGA Cosmic COSV5625, Variant assessed as somatic; high impact.
- Q52E (p.Gln52Glu), NCI-TCGA Cosmic COSV5625, cosmic curated COSV56258, Variant assessed as somatic; moderate impact.
- Q52K (p.Gln52Lys), rs1752706120, gnomAD 5-148070388-AT-A, CADD 13.60
- S53T (p.Ser53Thr), Ensembl rs2127189609, REVEL 0.05, MetaLR 0.03
- S53R (p.Ser53Arg), gnomAD 5-148070400-T-A, REVEL 0.09, MetaLR 0.04
- D55* (p.Asp55Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D55E (p.Asp55Glu), TOPMed rs1419424149, gnomAD rs1419424149, REVEL 0.01, MetaLR 0.03
- D55N (p.Asp55Asn), gnomAD rs1224127241
- D55Y (p.Asp55Tyr), cosmic curated COSV10455
- D55G (p.Asp55Gly), gnomAD 5-148070405-A-G, REVEL 0.19, MetaLR 0.07
- D55D (p.Asp55Asp), gnomAD 5-148070406-T-C, CADD 0.39
- G56A (p.Gly56Ala), 1000Genomes rs540712189, ExAC rs540712189, REVEL 0.05, MetaLR 0.05
- G56E (p.Gly56Glu), cosmic curated COSV10719, REVEL 0.09, MetaLR 0.04
- G56R (p.Gly56Arg), rs748409924, NCI-TCGA Cosmic COSV9980, cosmic curated COSV99806, ExAC rs748409924, REVEL 0.17, MetaLR 0.06, Variant assessed as somatic; moderate impact.
- G56* (p.Gly56Ter), gnomAD 5-148070407-G-T, CADD 34.00
- G56V (p.Gly56Val), gnomAD 5-148070408-G-T, REVEL 0.15, MetaLR 0.08
- I57L (p.Ile57Leu), TOPMed rs1159899850
- I57del (p.Ile57del), rs1477763174, gnomAD 5-148070408-GAAT-, CADD 6.86
- M58I (p.Met58Ile), rs771729229, ClinGen CA3495121, ClinVar RCV002693460, ExAC rs771729229, REVEL 0.08, MetaLR 0.01, Uncertain significance, Inborn genetic diseases
- M58T (p.Met58Thr), rs773557840, ClinGen CA3495120, ClinVar RCV001924317, ExAC rs773557840, REVEL 0.08, MetaLR 0.01, Uncertain significance, Netherton syndrome
- M58V (p.Met58Val), gnomAD 5-148070413-A-G, REVEL 0.05, MetaLR 0.01
- F59L (p.Phe59Leu), NCI-TCGA Cosmic COSV5626, cosmic curated COSV56261, REVEL 0.04, MetaLR 0.02, Variant assessed as somatic; moderate impact.
- F59F (p.Phe59Phe), gnomAD 5-148070418-C-T, CADD 8.58
- I60S (p.Ile60Ser), Ensembl rs75257702
- I60V (p.Ile60Val), rs1438419399, ClinGen CA361888505, ClinVar RCV001068597, gnomAD rs1438419399, REVEL 0.00, MetaLR 0.01, Uncertain significance, Netherton syndrome
- I60I (p.Ile60Ile), rs766432990, gnomAD 5-148070421-C-T, CADD 10.00
- N61S (p.Asn61Ser), rs377031902, ClinGen CA3495123, ClinVar RCV006465817, ESP rs377031902, REVEL 0.04, MetaLR 0.04, Uncertain significance, Ichthyosis linearis circumflexa
- K62E (p.Lys62Glu), gnomAD rs1405582913, REVEL 0.04, MetaLR 0.01
- K62N (p.Lys62Asn), cosmic curated COSV56249, gnomAD rs1325198281
- K62R (p.Lys62Arg), cosmic curated COSV56257
- C63Y (p.Cys63Tyr), ExAC rs759615234, gnomAD rs759615234, REVEL 0.67, MetaLR 0.71
- A64D (p.Ala64Asp), cosmic curated COSV10719
- A64S (p.Ala64Ser), Ensembl rs1752708069
- A64V (p.Ala64Val), NCI-TCGA Cosmic COSV5624, cosmic curated COSV56248, REVEL 0.07, MetaLR 0.02, Variant assessed as somatic; moderate impact.
- A64A (p.Ala64Ala), gnomAD 5-148070433-C-T, CADD 6.62
- T65M (p.Thr65Met), rs552548594, ClinGen CA3495125, NCI-TCGA Cosmic COSV9980, cosmic curated COSV99806, REVEL 0.03, MetaLR 0.01, Uncertain significance, not provided; Ichthyosis linearis circumflexa
- T65P (p.Thr65Pro), Ensembl rs2127189698
- T65R (p.Thr65Arg), 1000Genomes rs552548594, ExAC rs552548594, TOPMed rs552548594, gnomAD rs552548594, Uncertain significance
- T65T (p.Thr65Thr), rs370397387, gnomAD 5-148070436-G-A, CADD 0.06
- K67K (p.Lys67Lys), rs765120512, gnomAD 5-148070442-A-G, CADD 8.09
- M68I (p.Met68Ile), TOPMed rs1260851843, REVEL 0.02, MetaLR 0.02
- M68V (p.Met68Val), gnomAD 5-148070443-A-G, REVEL 0.02, MetaLR 0.01
- I69=, NCI-TCGA Cosmic COSV9980, Variant assessed as somatic; low impact.
- I69M (p.Ile69Met), rs2531646360, ClinGen CA361888643, ClinVar RCV003304416, Uncertain significance, Inborn genetic diseases
- L70M (p.Leu70Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L70R (p.Leu70Arg), NCI-TCGA Cosmic COSV9980, cosmic curated COSV99807, Variant assessed as somatic; moderate impact.
- L70L (p.Leu70Leu), gnomAD 5-148070449-C-T, CADD 2.63
- E71* (p.Glu71Ter), rs761010013, ClinGen CA361888756, ClinVar RCV003596332, Pathogenic
- E71K (p.Glu71Lys), rs761010013, ClinGen CA3495147, cosmic curated COSV56262, ClinVar RCV003595670, REVEL 0.12, MetaLR 0.04, Uncertain significance, Ichthyosis linearis circumflexa
- E71G (p.Glu71Gly), gnomAD 5-148072150-A-G, REVEL 0.11, MetaLR 0.06
- K72E (p.Lys72Glu), ExAC rs764931501, gnomAD rs764931501, REVEL 0.04, MetaLR 0.02
- E73* (p.Glu73Ter), NCI-TCGA Cosmic COSV9980, cosmic curated COSV99807, Variant assessed as somatic; high impact.
- E73K (p.Glu73Lys), gnomAD 5-148072149-GA-G, CADD 24.30
- A74S (p.Ala74Ser), TOPMed rs1752756435
- A74V (p.Ala74Val), gnomAD 5-148072159-C-T, REVEL 0.05, MetaLR 0.03
- K75Q (p.Lys75Gln), ExAC rs750301893, TOPMed rs750301893, gnomAD rs750301893
- Q77R (p.Gln77Arg), rs2531649900, ClinGen CA361888837, ClinVar RCV003212753, REVEL 0.03, MetaLR 0.10, Uncertain significance, Inborn genetic diseases
- K78E (p.Lys78Glu), ExAC rs762849019, TOPMed rs762849019, gnomAD rs762849019, REVEL 0.09, MetaLR 0.09
- K78K (p.Lys78Lys), gnomAD 5-148072172-G-A, CADD 0.85
Public SPINK5 analysis runs
- SPINK5 analysis run — SPINK5 (1,687 variants) — completed 2026-08-22